These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18366862)

  • 1. Treatment of glaucoma patients with insufficient intraocular pressure control: a survey of German ophthalmologists in private practice.
    Vorwerk C; Thelen U; Buchholz P; Kimmich F
    Curr Med Res Opin; 2008 May; 24(5):1295-301. PubMed ID: 18366862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
    J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma.
    Tamada Y; Taniguchi T; Murase H; Yamamoto T; Kitazawa Y
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):19-25. PubMed ID: 11322634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
    Simmons ST; Earl ML;
    Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of unoprostone isopropyl as an adjunct to topical beta-blocker in patients with open angle glaucoma: a-6-month study.
    Leelachaikul Y; Euswas A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S100-4. PubMed ID: 16681060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ocular hypotensive medication types with dynamic contour tonometry and Goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population.
    Tzamalis A; Kynigopoulos M; Chalvatzis N; Dimitrakos S; Schlote T
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):41-7. PubMed ID: 23066787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany.
    Thelen U; Buchholz P; Kimmich F
    Curr Med Res Opin; 2009 Apr; 25(4):1003-9. PubMed ID: 19275517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure control and persistence on treatment in glaucoma and ocular hypertension.
    Tingey D; Bernard LM; Grima DT; Miller B; Lam A
    Can J Ophthalmol; 2005 Apr; 40(2):161-9. PubMed ID: 16049529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure-lowering combination therapies with prostaglandin analogues.
    Aptel F; Chiquet C; Romanet JP
    Drugs; 2012 Jul; 72(10):1355-71. PubMed ID: 22686588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
    Martinez A; Sanchez M
    Curr Med Res Opin; 2007 May; 23(5):1025-32. PubMed ID: 17519068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension.
    Yamamoto T; Ikegami T; Ishikawa Y; Kikuchi S;
    Am J Ophthalmol; 2016 Nov; 171():35-46. PubMed ID: 27565224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
    Quigley HA; Friedman DS; Hahn SR
    Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database.
    Lazaridou MN; Montgomery DM; Ho WO; Jaberoo D
    Curr Med Res Opin; 2008 Oct; 24(10):2725-8. PubMed ID: 18713491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
    Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
    Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J
    Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.